Table 1_GLP-1 agonists and exercise: the future of lifestyle prioritization.docx
<p>Recent literature shows that GLP-1 receptor agonists are highly effective for weight loss and improving metabolic and cardiovascular health, often surpassing the results of lifestyle interventions alone, such as exercise and diet modification. However, long-term weight maintenance is more s...
Furkejuvvon:
| Váldodahkki: | |
|---|---|
| Eará dahkkit: | , |
| Almmustuhtton: |
2025
|
| Fáttát: | |
| Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
| _version_ | 1849927644770992128 |
|---|---|
| author | Roberto Codella (5856173) |
| author2 | Pamela Senesi (12083165) Livio Luzi (461070) |
| author2_role | author author |
| author_facet | Roberto Codella (5856173) Pamela Senesi (12083165) Livio Luzi (461070) |
| author_role | author |
| dc.creator.none.fl_str_mv | Roberto Codella (5856173) Pamela Senesi (12083165) Livio Luzi (461070) |
| dc.date.none.fl_str_mv | 2025-11-24T12:45:25Z |
| dc.identifier.none.fl_str_mv | 10.3389/fcdhc.2025.1720794.s001 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Table_1_GLP-1_agonists_and_exercise_the_future_of_lifestyle_prioritization_docx/30694658 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Metabolic Medicine type 2 diabetes exercise-as-a-medicine training metabolism health |
| dc.title.none.fl_str_mv | Table 1_GLP-1 agonists and exercise: the future of lifestyle prioritization.docx |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Recent literature shows that GLP-1 receptor agonists are highly effective for weight loss and improving metabolic and cardiovascular health, often surpassing the results of lifestyle interventions alone, such as exercise and diet modification. However, long-term weight maintenance is more successful when exercise is included, as stopping GLP-1 therapy alone often leads to weight regain, while exercise helps preserve muscle mass and sustain weight loss. Combining GLP-1 receptor agonists with structured lifestyle changes, especially increased protein intake and strength training, can mitigate muscle loss and enhance overall outcomes. As a result, future obesity management is likely to prioritize integrated approaches that combine pharmacotherapy with lifestyle interventions, rather than replacing lifestyle changes with medication alone.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_d0974667109de14c0f1a96104bd823a1 |
| identifier_str_mv | 10.3389/fcdhc.2025.1720794.s001 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30694658 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Table 1_GLP-1 agonists and exercise: the future of lifestyle prioritization.docxRoberto Codella (5856173)Pamela Senesi (12083165)Livio Luzi (461070)Metabolic Medicinetype 2 diabetesexercise-as-a-medicinetrainingmetabolismhealth<p>Recent literature shows that GLP-1 receptor agonists are highly effective for weight loss and improving metabolic and cardiovascular health, often surpassing the results of lifestyle interventions alone, such as exercise and diet modification. However, long-term weight maintenance is more successful when exercise is included, as stopping GLP-1 therapy alone often leads to weight regain, while exercise helps preserve muscle mass and sustain weight loss. Combining GLP-1 receptor agonists with structured lifestyle changes, especially increased protein intake and strength training, can mitigate muscle loss and enhance overall outcomes. As a result, future obesity management is likely to prioritize integrated approaches that combine pharmacotherapy with lifestyle interventions, rather than replacing lifestyle changes with medication alone.</p>2025-11-24T12:45:25ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.3389/fcdhc.2025.1720794.s001https://figshare.com/articles/dataset/Table_1_GLP-1_agonists_and_exercise_the_future_of_lifestyle_prioritization_docx/30694658CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/306946582025-11-24T12:45:25Z |
| spellingShingle | Table 1_GLP-1 agonists and exercise: the future of lifestyle prioritization.docx Roberto Codella (5856173) Metabolic Medicine type 2 diabetes exercise-as-a-medicine training metabolism health |
| status_str | publishedVersion |
| title | Table 1_GLP-1 agonists and exercise: the future of lifestyle prioritization.docx |
| title_full | Table 1_GLP-1 agonists and exercise: the future of lifestyle prioritization.docx |
| title_fullStr | Table 1_GLP-1 agonists and exercise: the future of lifestyle prioritization.docx |
| title_full_unstemmed | Table 1_GLP-1 agonists and exercise: the future of lifestyle prioritization.docx |
| title_short | Table 1_GLP-1 agonists and exercise: the future of lifestyle prioritization.docx |
| title_sort | Table 1_GLP-1 agonists and exercise: the future of lifestyle prioritization.docx |
| topic | Metabolic Medicine type 2 diabetes exercise-as-a-medicine training metabolism health |